News

GPI partners with Datarade

2 June 2021
Posted in

Global Pricing Innovations, leading provider of pharma pricing insights, has joined Datarade, the fastest-growing data marketplace. Datarade’s tens of thousands of data buyers from every industry can now effortlessly discover, compare, and get access to GPI’s data products.

Read More

Model N and Global Pricing Innovations Announce Strategic Partnership

28 April 2021
Posted in

The partnership with Model N delivers scalable technology and services that enable data-powered insights, achieving measurable impact on global customer pricing and market access decision-making.

Read More

GPI featured in JP Morgan ‘Top 200 female-powered businesses’

27 April 2021
Posted in

JP Morgan have a long standing commitment to supporting and promoting female-powered businesses, and this report highlights the changes we are seeing across all markets, globally.

Read More

GPI launches updated pricing and market access analytics platform

15 April 2021
Posted in

Global Pricing Innovations (GPI), announce innovative solution to empower insightful decision-making for the BioPharma industry. GPI pulse™ 2.0 launches, providing a more intuitive and powerful analytics platform.

Read More

Quarterly GPI Values Awards – Q1

9 April 2021
Posted in

At GPI, our work is centred around our FOUR core values: Quality Matters, Sustainability, Authenticity and Collaboration. Every day, our amazing staff go above and beyond for our customers and strive to maintain the high quality standards and values that GPI stands for.

Read More

Innovative drugs manufactured in France will match highest price on European Market

11 March 2021
Posted in

The French state-industry drug framework agreement stipulates that innovative drugs manufactured in the country can have the same initial price as the highest one applied in Germany, the UK, Italy, or Spain The new 2021-24 framework agreement signed on Friday 5th March between France’s healthcare products committee CEPS and French pharma body Leem includes a…

Read More

Pfizer-BioNTech alliance declare success for vaccine against COVID-19

11 November 2020
Posted in

Pfizer and BioNTech have announced positive interim Phase III results for their mRNA-based COVID-19 vaccine, BNT162b2, suggesting that it is 90% effective in preventing infection.

Read More

Pharma industry concerned about recent PMPRB guidelines for IRP in Canada

28 October 2020
Posted in

Canada is due to adjust its international reference pricing (#IRP) basket of comparator countries come January, the 1st, 2021.

Read More

Germany’s GKV-SV targets to increase medicines’ spending ceiling by 4.6% in 2021

13 October 2020
Posted in

The spending adjustments have occurred to account for “the use of innovative drugs” (+4.6%), with a price reductions of -0.2% and a shift between service areas of community physicians and hospitals of +0.2%, according to the agreement dated 1 October.

Read More

White House blocks new FDA safety guidelines on COVID-19 vaccine approval

6 October 2020
Posted in

The new FDA guidelines were submitted for approval to the Office of Management and Budget on September 21, although they stalled with White House Chief of Staff, Mark Meadows.

Read More